Author: George Underwood

Includes data for head and neck cancer, biliary tract cancer and esophageal cancers

MSD’s immunotherapy improved overall survival by up to 39%

Drug improved progression-free survival by 70%

Positive results in lung and breast cancer, but Roche is still playing catch-up to rival drugs

AMI-MS delivers a twenty-fold improvement in throughput compared to traditional mass spectrometry by using sound energy